
About Xenex
Xenex is a Healthcare company based in San Antonio (United States) founded in 2009. Disinfection robots with UV technology are supplied for healthcare sterilization. It operates in the Healthcare and Industrial Goods & Manufacturing sectors. Xenex has raised $94.39 million across 6 funding rounds from investors including Piper Jaffray, Malin PLC and Tectonic Ventures. Xenex offers products and services including LightStrike+ Robot, LightStrike6, Deactivate Handheld LED Unit, and TrackMate Digital Tracking System. Its focus areas include Life Sciences, Infectious Diseases, Medical Devices and Decontamination Solutions. Its legal entity is Xenex Disinfection Services Inc.
Company details
Xenex was established in 2009 in San Antonio, United States, within the healthcare sector. Disinfection robots are offered by the company for hospital room sterilization, utilizing patented Xenon Pulse UV technology. Microorganisms causing infections are targeted and eliminated by this system, which reduces bacterial loads linked to healthcare-associated infections. Operations focus on supporting facilities in preventing such risks through automated UV-based processes.
- Total Equity Funding$94.39M (USD)
in 6 rounds
- Latest Funding Round$6.02M (USD), Series D
Feb 2019
- InvestorsPiper Jaffray
& 7 more
Products & Services of Xenex
Xenex offers a comprehensive portfolio of products and services, including LightStrike+ Robot, LightStrike6, Deactivate Handheld LED Unit, and TrackMate Digital Tracking System.
UV robot for rapid pathogen reduction in healthcare rooms
Advanced UV system for microbial deactivation in facilities
Handheld device to reduce pathogens on surfaces
System for tracking disinfection processes in environments
Apps and channels of Xenex
its YouTube channel Xenex Disinfection has 770 subscribers and 30 videos.
Videos from Xenex
The most watched videos on Xenex's YouTube channel, Xenex Disinfection (770 subscribers). Click a video to play it here.
More on Xenex Disinfection.
Funding Insights of Xenex
Xenex has successfully raised a total of $94.39M across 6 strategic funding rounds. The most recent funding activity was a Series D round of $6.02 million completed in February 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $94.39M
- Total Rounds 6
- Last Round Series D β $6.02M
- First Round $9.02M
(Sep 2012)
- Investors Count 8
All 6 funding rounds of Xenex with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb 2019 | $6.02M | Series D | β | β | β |
| Feb 2018 | $40M | Series D | β | EW Healthcare Partners | |
| Sep 2016 | $3M | Series C | β | β | β |
| Jan 2015 | $25M | Series C | β | Brandon Point Industries | |
| Dec 2013 | $11.36M | Series B | β | Battery Ventures, Targeted Technology | β |
| Sep 2012 | $9.02M | Series A | β | β | β |
8 investors in total: 8 institutional.
Investors in Xenex
Xenex has secured backing from 8 investors, including institutional and venture fund investors. Prominent investors backing the company include Piper Jaffray, Malin PLC and Tectonic Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
| tectonicventures.com | ||||
Growth-stage healthcare companies are invested in by EW Healthcare Partners. | ewhealthcare.com | New York, United States | ||
Investments in technology companies are conducted globally by Battery Ventures. | battery.com | |||
| brandonpti.com | ||||
Early stage investments in medical and life science technologies are made by Targeted Technology. | targetedtech.com | San Antonio, United States | ||
Entrepreneurial ventures are supported by RK Ventures with capital. | rkventures.com | New York, United States | ||
Middle market focused investment bank | 1895 | piperjaffray.com | Minneapolis, United States | |
Malin PLC is engaged in investing in life sciences companies. | malinplc.com | Dublin, Ireland |
Investor details for Xenex
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Xenex
3 dated milestones of Xenex across 10 years, from founding to its latest funding, stage changes and deals.
- Founded Xenex is founded.
- Funding First funding round of $9.0M.
- Funding Latest funding round, Series D, of $6.0M.
Web traffic of Xenex
The website of Xenex (xenex.com) receives about 4K visits a month.
- Monthly visits4K
▼ 9.4% vs previous month
Websites whose visitors overlap most with Xenex. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
healthcareitnews.com | healthcareitnews.com | 100% | #409,888 | β | |
scican.com | scican.com | 96% | #1,679,918 | β | |
infectioncontroltoday.com | infectioncontroltoday.com | 61% | #808,049 | β | |
gracehc.com | gracehc.com | 59% | β | ||
his.org.uk | his.org.uk | 58% | #1,976,153 | β | |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
All 8 similar websites and full traffic analytics for Xenex
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 8 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Medical Equipment & Supplies
3 companies that operate in the same segment as Xenex (Medical Equipment & Supplies) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Robotic waterjet system for prostate tissue removal is developed. | 2009 | Redwood City, California, United States | USD 348.84 M | USD 308.05 M | 756 | |
Robotic microsurgical systems for endoscopy are developed. | 2007 | Redwood City, California, United States | USD 733.62 M | 91 | ||
Injectable packaging, containment, and delivery solutions are manufactured. | 1923 | Exton, Pennsylvania, United States | USD 3.07 B | 10,600 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Xenex
Complete news archive for Xenex
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Xenex
Xenex was founded in 2009 and raised its 1st funding round 3 years after it was founded.
Xenex is headquartered in San Antonio, United States. It is registered at San Antonio, Texas, United States.
Xenex is a funded company, having raised a total of $94.39M across 6 funding rounds to date. The company's 1st funding round was a Series A of $9.02M, raised on Sep 2012.
Xenex was established in 2009 in San Antonio, United States, within the healthcare sector. Disinfection robots are offered by the company for hospital room sterilization, utilizing patented Xenon Pulse UV technology. Microorganisms causing infections are targeted and eliminated by this system, which reduces bacterial loads linked to healthcare-associated infections. Operations focus on supporting facilities in preventing such risks through automated UV-based processes.
Xenex offers LightStrike+ Robot, LightStrike6, Deactivate Handheld LED Unit, and TrackMate Digital Tracking System.
Xenex has 8 investors. Key investors include Piper Jaffray, Malin PLC, Tectonic Ventures, EW Healthcare Partners, and Battery Ventures.
Xenex operates through Xenex Disinfection Services Inc..
